Personalis Quick Ratio 2018-2025 | PSNL

Historical quick ratio values for Personalis (PSNL) over the last 10 years.
Personalis Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2025-03-31 $0.20B $0.03B 6.74
2024-12-31 $0.20B $0.03B 6.33
2024-09-30 $0.16B $0.04B 4.44
2024-06-30 $0.10B $0.03B 3.05
2024-03-31 $0.11B $0.03B 3.56
2023-12-31 $0.14B $0.05B 2.89
2023-09-30 $0.14B $0.03B 4.31
2023-06-30 $0.15B $0.03B 5.35
2023-03-31 $0.18B $0.03B 5.11
2022-12-31 $0.19B $0.03B 5.77
2022-09-30 $0.21B $0.03B 6.35
2022-06-30 $0.25B $0.04B 6.08
2022-03-31 $0.29B $0.04B 7.18
2021-12-31 $0.31B $0.03B 9.98
2021-09-30 $0.32B $0.03B 12.20
2021-06-30 $0.35B $0.03B 10.18
2021-03-31 $0.37B $0.04B 9.52
2020-12-31 $0.22B $0.04B 5.29
2020-09-30 $0.22B $0.04B 6.05
2020-06-30 $0.11B $0.04B 2.64
2020-03-31 $0.13B $0.05B 2.48
2019-12-31 $0.14B $0.05B 2.70
2019-09-30 $0.14B $0.05B 2.86
2019-06-30 $0.17B $0.06B 3.06
2019-03-31 $0.00B 0.00
2018-12-31 $0.00B 0.00
2018-09-30 $0.00B 0.00
2018-06-30 $0.00B 0.00
2017-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.414B $0.085B
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.080B 7.26
Dr Reddy's Laboratories (RDY) India $12.313B 22.35
BridgeBio Pharma (BBIO) United States $6.285B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.825B 14.82
Bausch Health Cos (BHC) Canada $1.673B 1.22
Amphastar Pharmaceuticals (AMPH) United States $1.213B 8.08
Taysha Gene Therapies (TSHA) United States $0.559B 0.00
Assembly Biosciences (ASMB) United States $0.108B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Evoke Pharma (EVOK) United States $0.006B 0.00
Teligent (TLGT) United States $0.000B 0.00